Literature DB >> 21474451

Switching of N-methyl-D-aspartate (NMDA) receptor-favorite intracellular signal pathways from ERK1/2 protein to p38 mitogen-activated protein kinase leads to developmental changes in NMDA neurotoxicity.

Lin Xiao1, Chun Hu, Chunzhi Feng, Yizhang Chen.   

Abstract

Excitotoxicity mediated by overactivation of N-methyl-D-aspartate receptors (NMDARs) has been implicated in a variety of neuropathological conditions in the central nervous system (CNS). It has been suggested that N-methyl-D-aspartate (NMDA) neurotoxicity is developmentally regulated, but the definite pattern of the regulation has been controversial, and the underlying mechanism remains largely unknown. Here, we show that NMDA treatment leads to significant cell death in mature (9 and 12 days in vitro) hippocampal neurons or hippocampi of young postnatal day 12 and adult rats but not in immature (3 and 6 days in vitro) neurons or embryonic day 18 and neonatal rat hippocampi. In contrast, NMDA promotes survival of immature neurons against tropic deprivation. Interestingly, it is found that NMDA preferentially activates p38 MAPK in mature neuron and adult rat hippocampus, but it favors ERK1/2 activation in immature neuron and postnatal day 0 rat hippocampus. Moreover, it is shown that NMDA neurotoxicity in mature neuron is mediated via p38 MAPK activation, and neuroprotection in immature neuron is mediated via ERK1/2 activation, whereas all these effects are NR2B-containing NMDAR-dependent, as well as Ca(2+)-dependent. We also revealed that mature and immature neurons showed no difference in the amplitude of NMDA-induced intracellular calcium ([Ca(2+)](i)) increase. However, the basal level of [Ca(2+)](i) is shown to elevate with the maturation of neuron, and this elevation is attributable to the changes in NMDA neurotoxicity but not to the switch of the NMDAR signaling pathway. Taken together, our results suggest that a switch of NMDA receptor-favorite intracellular signal pathways from ERK1/2 to p38 MAPK and the elevated basal level of [Ca(2+)](i) with age might be critical for the developmental changes in NMDA neurotoxicity in the hippocampal neuron.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474451      PMCID: PMC3121511          DOI: 10.1074/jbc.M110.188854

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death.

Authors:  B Fogal; J Trettel; T F Uliasz; E S Levine; S J Hewett
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

2.  Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons.

Authors:  J H Li; Y H Wang; B B Wolfe; K E Krueger; L Corsi; G Stocca; S Vicini
Journal:  Eur J Neurosci       Date:  1998-05       Impact factor: 3.386

3.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

Authors:  C Ikonomidou; F Bosch; M Miksa; P Bittigau; J Vöckler; K Dikranian; T I Tenkova; V Stefovska; L Turski; J W Olney
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

4.  The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro.

Authors:  K R Tovar; G L Westbrook
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

5.  Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.

Authors:  Jian Xu; Pradeep Kurup; Yongfang Zhang; Susan M Goebel-Goody; Peter H Wu; Ammar H Hawasli; Matthew L Baum; James A Bibb; Paul J Lombroso
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

6.  In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease.

Authors:  Mary Y Heng; Peter J Detloff; Phillip L Wang; Joe Z Tsien; Roger L Albin
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

7.  Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity.

Authors:  R Sattler; M P Charlton; M Hafner; M Tymianski
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

Review 8.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

9.  N-methyl-D-aspartate-stimulated ERK1/2 signaling and the transcriptional up-regulation of plasticity-related genes are developmentally regulated following in vitro neuronal maturation.

Authors:  Xianju Zhou; Changjong Moon; Fei Zheng; Yongneng Luo; Deborah Soellner; Joseph L Nuñez; Hongbing Wang
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

10.  Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades.

Authors:  Jun Chen; Milan Rusnak; Paul J Lombroso; Anita Sidhu
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

View more
  10 in total

1.  Ionotropic NMDA receptor signaling is required for the induction of long-term depression in the mouse hippocampal CA1 region.

Authors:  Walter E Babiec; Ryan Guglietta; Shekib A Jami; Wade Morishita; Robert C Malenka; Thomas J O'Dell
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

2.  Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.

Authors:  Da-Zhi Liu; Frank R Sharp
Journal:  Transl Stroke Res       Date:  2012-03-15       Impact factor: 6.829

Review 3.  N-Methyl-D-Aspartate Receptor Signaling and Function in Cardiovascular Tissues.

Authors:  Marie A McGee; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2016-08       Impact factor: 3.105

4.  17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease.

Authors:  Ferdinando Nicoletti; Ingrid Philippens; Paolo Fagone; Clarence N Ahlem; Christopher L Reading; James M Frincke; Dominick L Auci
Journal:  Parkinsons Dis       Date:  2012-09-26

Review 5.  Mature neurons: equipped for survival.

Authors:  A J Kole; R P Annis; M Deshmukh
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

6.  Decreased levels of pNR1 S897 protein in the cortex of neonatal Sprague Dawley rats with hypoxic-ischemic or NMDA-induced brain damage.

Authors:  Ming-Yan Hei; Hui-Kang Tao; Qin Tang; Bo Yu; Ling-Ling Zhao
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

7.  Reduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice.

Authors:  Shan-May Yong; Mei-Li Lim; Chian-Ming Low; Boon-Seng Wong
Journal:  Sci Rep       Date:  2014-10-10       Impact factor: 4.379

8.  Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.

Authors:  Todd D Prickett; Brad J Zerlanko; Victoria K Hill; Jared J Gartner; Nouar Qutob; Jiji Jiang; May Simaan; John Wunderlich; J Silvio Gutkind; Steven A Rosenberg; Yardena Samuels
Journal:  J Invest Dermatol       Date:  2014-04-16       Impact factor: 8.551

9.  The expression profile of developmental stage-dependent circular RNA in the immature rat retina.

Authors:  Junde Han; Lingqi Gao; Jing Dong; Jie Bai; Mazhong Zhang; Jijian Zheng
Journal:  Mol Vis       Date:  2017-07-20       Impact factor: 2.367

Review 10.  Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials.

Authors:  Liwei Pang; Meiying Cui; Wanling Dai; Jing Kong; Hongzhi Chen; Shuodong Wu
Journal:  Front Pharmacol       Date:  2020-10-19       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.